| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 1, Issue 8 345-350, Copyright © 1990 by American Association of Cancer Research
ARTICLES |
RJ Grumont and S Gerondakis
Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Parkville, Victoria, Australia.
The c-rel protooncogene is here shown to be a member of the early response gene family. Expression induced by different agents is regulated by both transcriptional and posttranscriptional mechanisms. In quiescent fibroblasts, c-rel expression is maximally induced by serum or 12-O-tetradecanoylphorbol-13-acetate within 60 min and is superinduced in serum-stimulated fibroblasts by cycloheximide. In T-cells, although 12-O-tetradecanoylphorbol-13-acetate and concanavalin A both rapidly activate c-rel expression, the kinetics of induction mediated by these agents differs markedly. Nuclear run-on analysis demonstrates that induced c-rel expression is due primarily to increased transcription, and the rapid decrease in expression observed in serum- and 12-O-tetradecanoylphorbol-13-acetate-stimulated cells results from mRNA turnover. In the B-lymphoid lineage, c-rel is constitutively transcribed, with the differentiation stage-specific decrease in c-rel expression seen in plasmacytomas reflecting posttranscriptional regulation.
This article has been cited by other articles:
![]() |
R. J. Grumont, I. J. Rourke, L. A. O'Reilly, A. Strasser, K. Miyake, W. Sha, and S. Gerondakis B Lymphocytes Differentially Use the Rel and Nuclear Factor {kappa}B1 (NF-{kappa}B1) Transcription Factors to Regulate Cell Cycle Progression and Apoptosis in Quiescent and Mitogen-activated Cells J. Exp. Med., March 2, 1998; 187(5): 663 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Kontgen, R J Grumont, A Strasser, D Metcalf, R Li, D Tarlinton, and S Gerondakis Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes & Dev., August 15, 1995; 9(16): 1965 - 1977. [Abstract] [PDF] |
||||
![]() |
D Carrasco, R. Ryseck, and R Bravo Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells Development, January 8, 1993; 118(4): 1221 - 1231. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |